TAVISTOCK LIFE SCIENCES
Tavistock Life Sciences is a venture capital investment firm specialized in earl-stage investments.
TAVISTOCK LIFE SCIENCES
Social Links:
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
LetsEncrypt Font Awesome Amazon Pound Sterling IIS 10 Microsoft ASP.NET 4.0 Microsoft Azure ASP.NET Ajax Smart App Banner
Similar Organizations
Backswing Ventures
Backswing Ventures is a $50m venture fund investing in early stage companies in a broad range of industries.
Riverfront Ventures
Riverfront Ventures is a venture capital firm specializing in seed and early-stage investments.
Current Advisors List
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-10-17 | Avidity Biosciences | Tavistock Life Sciences investment in Series B - Avidity Biosciences | 16 M USD |
| 2018-04-03 | Poseida Therapeutics | Tavistock Life Sciences investment in Series B - Poseida Therapeutics | 30.5 M USD |
| 2016-05-11 | G1 Therapeutics | Tavistock Life Sciences investment in Series C - G1 Therapeutics | 47 M USD |
| 2015-08-24 | Syndax Pharmaceuticals | Tavistock Life Sciences investment in Series C - Syndax Pharmaceuticals | 80 M USD |
| 2015-03-12 | Kura Oncology | Tavistock Life Sciences investment in Private Equity Round - Kura Oncology | 60 M USD |
| 2014-11-12 | Blueprint Medicines | Tavistock Life Sciences investment in Series C - Blueprint Medicines | 50 M USD |
| 2014-04-16 | Nexvet | Tavistock Life Sciences investment in Series B - Nexvet | 31.5 M USD |
| 2012-11-21 | MethylGene | Tavistock Life Sciences investment in Venture Round - MethylGene | 26.13 M USD |
| 2009-07-08 | Somaxon Pharmaceuticals | Tavistock Life Sciences investment in Post-IPO Equity - Somaxon Pharmaceuticals | 6 M USD |
| 2009-04-01 | Ambrx | Tavistock Life Sciences investment in Series D - Ambrx | 10 M USD |